HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ting Lan Selected Research

Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)

4/2014Type II cGMP-dependent protein kinase inhibits ligand‑induced activation of EGFR in gastric cancer cells.
12/2013Type II cGMP-dependent protein kinase inhibits epidermal growth factor-induced phosphatidylinositol-3-kinase/Akt signal transduction in gastric cancer cells.
5/2013Type II cGMP-dependent protein kinase inhibits activation of key members of the RTK family in gastric cancer cells.
1/2013PKG II inhibits EGF/EGFR-induced migration of gastric cancer cells.
11/2012Type II cGMP-dependent protein kinase inhibits ERK/JNK-mediated activation of transcription factors in gastric cancer cells.
11/2012Endogenous cGMP-dependent protein kinase reverses EGF-induced MAPK/ERK signal transduction through phosphorylation of VASP at Ser239.
6/2012Type II cGMP-dependent protein kinase inhibits EGF-induced MAPK/JNK signal transduction in breast cancer cells.
2/2012Type II cGMP-dependent protein kinase inhibits EGF-triggered signal transduction of the MAPK/ERK-mediated pathway in gastric cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ting Lan Research Topics

Disease

27Neoplasms (Cancer)
11/2022 - 02/2012
16Stomach Neoplasms (Stomach Cancer)
10/2019 - 02/2012
4Prostatic Neoplasms (Prostate Cancer)
05/2022 - 01/2019
4Neoplasm Metastasis (Metastasis)
05/2022 - 10/2016
3Stroke (Strokes)
04/2022 - 01/2018
3Pain (Aches)
02/2022 - 03/2018
3Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 03/2020
3Fanconi Anemia (Fanconi's Anemia)
11/2017 - 05/2015
3Lung Neoplasms (Lung Cancer)
11/2017 - 11/2012
2Brain Injuries (Brain Injury)
04/2022 - 01/2018
2Neuralgia (Stump Neuralgia)
02/2022 - 12/2021
2Carcinogenesis
01/2022 - 06/2012
2Acne Vulgaris
01/2021 - 12/2018
2Hypoxia (Hypoxemia)
05/2020 - 11/2019
2Sepsis (Septicemia)
01/2020 - 01/2017
2Carcinoma (Carcinomatosis)
01/2019 - 01/2019
2Erythema
12/2018 - 03/2018
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018 - 11/2017
2Breast Neoplasms (Breast Cancer)
05/2015 - 06/2012
2Infections
05/2013 - 06/2012
1Teratoma (Teratoid Tumor)
03/2022
1Hypersensitivity (Allergy)
02/2022
1Chronic Pain
02/2022
1Heart Diseases (Heart Disease)
01/2022
1Squamous Cell Carcinoma of Head and Neck
01/2022
1Hyperglycemia
01/2022
1Hemorrhagic Stroke
01/2022
1Radiation Injuries (Radiation Sickness)
01/2022
1Ganglion Cysts (Ganglion)
12/2021
1Body Weight (Weight, Body)
12/2021
1Hyperalgesia
12/2021
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
03/2021
1Wounds and Injuries (Trauma)
01/2021
1Cicatrix (Scar)
01/2021
1Hypertension (High Blood Pressure)
01/2021
1Heart Failure
05/2020
1Heart Injuries
05/2020
1Endometrial Neoplasms (Endometrial Cancer)
01/2020
1Endotoxemia
01/2020
1Atrophy
01/2020
1Right Ventricular Hypertrophy
11/2019
1Pulmonary Hypertension
11/2019

Drug/Important Bio-Agent (IBA)

11Epidermal Growth Factor (EGF)IBA
11/2022 - 02/2012
10Complementary DNA (cDNA)IBA
10/2019 - 02/2012
8Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA
04/2014 - 02/2012
7ErbB Receptors (EGF Receptor)IBA
11/2022 - 02/2012
7Proteins (Proteins, Gene)FDA Link
02/2022 - 01/2017
78-((4-chlorophenyl)thio)cyclic-3',5'-GMPIBA
04/2014 - 02/2012
6Biomarkers (Surrogate Marker)IBA
11/2022 - 01/2019
6Phosphotransferases (Kinase)IBA
10/2019 - 11/2012
5Biological ProductsIBA
01/2022 - 01/2013
5Protein Kinases (Protein Kinase)IBA
08/2016 - 11/2012
5EnzymesIBA
07/2015 - 06/2012
4Pharmaceutical PreparationsIBA
01/2022 - 01/2019
3InflammasomesIBA
02/2022 - 01/2017
3Messenger RNA (mRNA)IBA
01/2022 - 01/2019
3Transcription Factors (Transcription Factor)IBA
01/2022 - 11/2012
3DNA (Deoxyribonucleic Acid)IBA
12/2021 - 05/2015
2LigandsIBA
05/2022 - 05/2013
22- (2- (2- chloro- 3- ((1,3- dihydro- 3,3- dimethyl- 1- propyl- 2H- indol- 2- ylidene)ethylidene)- 1- cyclohexen- 1- yl)ethenyl)- 3,3- dimethyl- 1- propylindoliumIBA
12/2020 - 08/2019
2cabazitaxelFDA Link
12/2020 - 08/2019
2Fluorescent Dyes (Fluorescent Probes)IBA
12/2020 - 08/2019
2Small Interfering RNA (siRNA)IBA
03/2020 - 10/2016
2RNA (Ribonucleic Acid)IBA
10/2019 - 01/2019
21-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2018 - 03/2018
2GemcitabineFDA Link
01/2018 - 11/2017
2Cisplatin (Platino)FDA LinkGeneric
12/2016 - 05/2015
2Guanosine Monophosphate (5' Guanylic Acid)IBA
07/2015 - 06/2015
1Threonine (L-Threonine)FDA Link
11/2022
1DisintegrinsIBA
05/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2022
1Ephrin-A5 (AL-1)IBA
05/2022
1U 0126 (UO 126)IBA
04/2022
1rhodiolosideIBA
02/2022
1Analgesics (Analgesic Drugs)IBA
02/2022
1GlucosidesIBA
02/2022
1Neuroprotective AgentsIBA
02/2022
1NLR ProteinsIBA
02/2022
1LactoferrinIBA
01/2022
1SirtuinsIBA
01/2022
1IntegrinsIBA
01/2022
1Cadherins (E-Cadherin)IBA
01/2022
1Caspase 3 (Caspase-3)IBA
01/2022
1Sirtuin 1IBA
01/2022
1cinnamaldehyde (cinnamic aldehyde)FDA Link
01/2022
1Streptozocin (Streptozotocin)FDA Link
01/2022
1Blood Glucose (Blood Sugar)IBA
12/2021
1cyclopropapyrroloindoleIBA
01/2021
1nitronyl nitroxideIBA
05/2020
1Epithelial Cell Adhesion MoleculeIBA
01/2020
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2020
1TRPC6 Cation ChannelIBA
11/2019
1CalciumIBA
11/2019

Therapy/Procedure

7Therapeutics
03/2022 - 07/2016
4Radiotherapy
01/2022 - 12/2016
2Drug Therapy (Chemotherapy)
08/2019 - 05/2015
2Photochemotherapy (Photodynamic Therapy)
12/2018 - 03/2018
1Intraperitoneal Injections
02/2022
1Transplantation
01/2022
1Castration
12/2020